Short Summary
This is a cost determination order from the Local Chamber Munich of the Unified Patent Court concerning a preliminary injunction proceeding. The parties had agreed out of court on the reimbursement amounts (EUR 195,000 for first instance representation, EUR 11,000 in court fees, and EUR 38,000 for appeal representation), totaling EUR 244,000. The sole disputed issue was whether Edwards was entitled to interest on the reimbursed costs at five percentage points above the German base rate. The court rejected the interest claim, holding that neither the UPCA nor the Rules of Procedure provide a legal basis for interest in cost determination proceedings.
Detailed Summary
This order was issued by the Local Chamber Munich of the Unified Patent Court on January 10, 2025, in a cost determination proceeding (Kostenfestsetzungsverfahren) related to a preliminary injunction proceeding (ACT_550921/2023, UPC_CFI_249/2023). The applicant, Edwards Lifesciences Corporation (represented by Bird & Bird), sought cost reimbursement from the respondents, Meril GmbH and Meril Life Sciences Pvt. Ltd. (represented by Hogan Lovells), under Rules 150 and 151 of the Rules of Procedure.
The parties had reached out-of-court agreements on the amounts to be reimbursed: EUR 195,000 for first-instance representation costs, EUR 11,000 in court fees for the first instance, and EUR 38,000 for appeal representation costs (the ceiling for reimbursable costs). The total undisputed amount was EUR 244,000.
The sole disputed point was Edwards' request that the determined costs bear interest at five percentage points above the respective base rate under § 247 of the German Civil Code (BGB), accruing from the date of filing of each application. Edwards argued that the reimbursement of interest before the UPC follows from the corresponding application of Rules 125 and 131 RoP. Edwards relied on Article 68(2) UPCA, which requires that the injured party be placed as far as possible in the position it would have been in without the infringement, arguing that without interest, the time value of money expended would be disregarded, causing the patent holder to suffer real losses from foregone interest gains. Edwards also pointed to No. 7 of the Preamble of the Rules of Procedure, which states that cost and/or damages decisions should be made simultaneously with or as soon as possible after the main action, arguing that this demonstrates a comparable interest in prompt cost decisions.
Meril opposed the interest claim, arguing that there is no legal basis for such interest in either the UPCA or the Rules of Procedure. Meril contended that Rules 125 and 131 RoP concern only the determination of damages and compensation, and that the absence of an interest provision in the cost determination rules was deliberate.
The court, presided over by Judge Matthias Zigann, rejected Edwards' interest claim. The court held that there is no legal basis for the reimbursement of interest in cost determination proceedings. Neither the UPCA nor the Rules of Procedure provide for interest on determined costs in such proceedings. The court found that the corresponding application of Rules 125 and 131 RoP—which govern the determination of damages and compensation and expressly provide for interest—was not warranted because there was no unintentional regulatory gap. The court reasoned that the very existence of those provisions shows the legislator was aware of the problems of time delay and inflation, yet deliberately chose not to provide for interest on cost reimbursement. The court noted that Rule 131.2(a) RoP requires the indication of interest in applications for damages determination, while the corresponding Rule 151 RoP for cost determination lacks any such provision. The court further observed that in preliminary injunction proceedings, the successful party can instead request provisional cost reimbursement and immediately enforce it (Rule 221 No. 1(d) RoP), and this possibility also exists before the Court of Appeal (Rule 242 No. 2(a) RoP). The court left open whether any actual interest damage could be claimed separately within the framework of damages calculation.
The final order required the respondents to pay Edwards a total of EUR 244,000.00 within 20 days of service of the order. The remainder of Edwards' application (i.e., the interest claim) was rejected. The order is subject to appeal under Rule 157 RoP via Rule 221 RoP, with a 15-day deadline from service to file an application for leave to appeal.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Munich (DE) Local Division. Understanding the court's reasoning in Edwards Lifesciences Corporation vs Meril GmbH, Meril Life Sciences Pvt. Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Abbott Diabetes Care Inc.vsDexcom International Limited
This procedural order concerns Dexcom's request to amend its counter claim for revocation in proceedings involving EP 4 070 727 B1. After Abbott withdrew part of its infringement claim regarding the Dexcom G7-System with a G7-Receiver, Dexcom sought to add a declaration of non-infringement for that product combination. The Judge-Rapporteur granted leave to amend, finding Dexcom could not reasonably have filed the amendment earlier, and allowed Abbott 30 days to respond.
OERLIKON TEXTILE G.M.B.H. & CO. K.GvsHIMSON ENGINEERING PRIVATE LIMITED
Unified Patent Court decision.
Suinno Mobile & AI Technologies Licensing OyvsMicrosoft Corporation
The applicant, Suinno Mobile & AI Technologies Licensing Oy, sought review of a security for costs order of EUR 300,000 imposed against it in its infringement action against Microsoft Corporation, requesting reduction to EUR 100,000 based on its subsequent reduction of damages claimed. The Court of First Instance dismissed the application, holding that the reduction in damages claimed was immaterial to the value of the proceedings, which reflects the claimant's objective interest at the time of filing, and that the applicant's other arguments constituted a critique of the original order that could only be raised on appeal.
Microsoft CorporationvsSuinno Mobile & AI Technologies Licensing Oy
Microsoft Corporation sought leave to appeal an order of the Court of First Instance of the Unified Patent Court (Central Division, Paris seat) that had granted the respondent, Suinno Mobile & AI Technologies Licensing Oy, leave to reduce its damages claim to €2 million in an infringement action concerning European patent EP 2 671 173. Microsoft argued that leave to appeal would clarify the scope and limits of the Court's powers in interpreting a party's request under Article 76(1) UPCA and the admissible scope of a Rule 263 RoP application. The panel rejected the request, finding that the issue raised was not the subject of different interpretations by UPC judges and would not affect the final decision on the merits.
Dolby International ABvsHP Deutschland GmbH & Others
This is a procedural order from the Local Chamber Düsseldorf concerning European Patent EP 3 490 258 B1. Upon a joint request by the parties, the court ordered a stay of proceedings pursuant to Rule 295(d) of the Rules of Procedure and cancelled the oral hearing previously scheduled for June 17, 2025.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.